|
Market Cap (4-Jul) $69,284,672 (532nd) |
Close (30-Jun) $0.78 |
Volume (30-Jun) 230,813 |
Shortsold (19-Jun) 25,352 (0.02%) (510th) |
|
52w High $0.94 |
52w Low $0.385 |
P/E 166.67 |
EPS -0.34 |
MVP released this announcement to the ASX on 13 November 2020, 16:18. The announcement is not marked as price sensitive, and is 12 page(s) in length and 275.36kb in size.
You can view all announcements from MVP and see how they appear on a price chart on the announcements page.
At the date of this announcement, MVP was 1.608% short sold according to ASIC data. It was ranked the 138th most shorted stock on the ASX. It remains ranked 510th as of the latest reported data (19 June 2025).
| Other Recent Announcements from MVP | |
|---|---|
| Change in substantial holding | 15 May 2023, 16:59 |
| Final Director's Interest Notice - D. Williams | 26 April 2023, 14:29 |
| Resignation of Director | 18 April 2023, 9:18 |
| Appendix 3G | 13 November 2020, 16:18 |
| Appendix 3G | 4 November 2020, 16:26 |
| MVP and MundiPharma cease Australian licensing agreement | 30 October 2020, 11:40 |
| MVP 2020 AGM | 30 October 2020, 8:27 |
You must be logged in to post a reply.
Medical Developments International 